Back to Agenda
Indonesia Town Hall
Session Chair(s)
Endang Wahjuningtyas Hoyaranda
President, Indonesian Association For the Study of Medicinals (IASMED), Indonesia
The Indonesian regulation for clinical research has shown a significant transformation during the past year, after practically being at a very low level for the past decade. The Ministry of Health, together with the Indonesian Drug and Food Regulatory Body are prepared to welcome global pharmaceutical companies to conduct researches in various hospitals in the country.
Learning Objective : Discuss the recent transformations in Indonesian clinical research regulations and their impact on the country's research environment; Recognize the opportunities and challenges for global pharmaceutical companies conducting clinical research in Indonesia under the new regulatory framework.
Speaker(s)
Budi Gunadi Sadikin
Minister, Ministry of Health, Indonesia
Indonesia’s Health Research Revolution: Fast-Tracking Innovation & Global Collaboration in Clinical Trials
Taruna Ikrar, MD
Chairperson, Indonesia Food and Drug Authority, Indonesia
Indonesia’s Regulatory Readiness in Embracing Clinical Trial Transformation
Indri Rooslamiati Supriadi
Head of BB Binomika (Parent Organization of INA-CRC), Indonesia Ministry of Health (MOH), Indonesia
INA-CRC: The Catalyst of Indonesia’s Clinical Trial Ecosystem Transformation
Yuli Felistia, MD
Head of Clinical Research Unit, Research Manager , National Brain Center, Mahar Mardjono Hospital, Indonesia
Strengthening Indonesia’s Clinical Research Quality: The Critical Role of Clinical Research Unit
Ria Christine Siagian
Director of Drug Registration, The Indonesian FDA (BPOM), Indonesia
Panelist
Have an account?